Global Nucleic Acid Labeling Market Size, Share, Forecast Report, 2020-2027

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 3 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 15 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 19 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 23 in /home/multiwpmr/public_html/report-details.php on line 448
The nucleic acid labeling market is projected to grow at a considerable CAGR of around 8% during the forecast period (2019-2025). The rapid production of indexed DNA groupings and assembly into new genomes has been possible due to the continuous efforts by life science research scientists' and specialists. This has have made significant contributions to the nucleic acid labeling market. In addition, technical advancements in the life science field have resulted in increased speed and a decrease in the cost of DNA fusion. These researchers became capable to design and incorporate adapted bacterial chromosomes which can be used as part of the development of cutting-edge biofuels, bio-items, renewable chemicals, and others.



The advancements in modern engineering have enabled scientists to build new sequences of DNA. New organisms that produce biofuels and excrete medical drugs are being designed by scientists with the aid of new advanced software systems and laboratory chemicals. In addition, growing research activities, creative and advanced nuclear acid labeling technologies, and growing R&D investments in drug discovery and production are also driving the growth of the global market for nucleic acid labeling. However, costly research methods, strict regulatory criteria are the factors that inhibit the growth of the global market for nucleic acid labeling. The rising US FDA approval for personalized medicine is anticipated to create opportunities for the growth of the global nucleic acid labeling market.



Segmental Outlook



The nucleic acid labeling market is segmented on the basis of labeling type, application, and end-user. Based on labeling type the market is segmented into biotin based, fluorescent, radioactive phosphates, and others. Biotin based labeling is anticipated to hold major market share based on labeling type during the forecast period. Based on application the market is segmented into PCR, microarray, in-situ hybridization, DNA sequencing, and others. Based on the application, PCR is anticipated to exhibit considerable growth during the forecast period. Based on end-user the market is segmented into hospitals, diagnostic centers, and others.



Biotin Based will be considerable segment by Labeling Type



Based on labeling type, the non-radioactive labeling type, such as biotin-based labeling is highly preferred owing to the harmful radioactive labeling. Biotin-based labeling has increased stability and is non-hazardous in nature. The biotin-based labels make use of non-toxic materials and are having faster detection rates in comparison to other radioactive labeling types. Furthermore, the long half-life, high stability, and high production capability in bulk and stored at -20�C for repeated uses are the key characteristics of the biotin based labeling which is anticipated to make major contributions towards the growth of the segment. Moreover, the ongoing advancements in biotin-based techniques, such as the addition of long tails of biotinylated nucleotides through enzymatic methods to further drive the growth of this market segment.



Regional Outlook



The global nucleic acid labeling market is further segmented on the basis of geography including North America, Europe, Asia-Pacific and Rest of the World. North America is anticipated to hold a major market share in the global Nucleic Acid Labeling market during the forecast period. The major factor for the high market share in the region is the substantial number and amount of funding for gene-editing technology in the US and Canada. Moreover, the presence of major market players in the US is supporting the considerable presence of North America in the market by investing a significant amount in R&D activities. North America is followed by Europe and the Asia Pacific is projected to be the fastest-growing market during the forecasted period.



Asia-Pacific will augment with the significant growth rate in the Nucleic Acid Labeling market



Asia-Pacific is expected to grow at a considerable CAGR during the forecast period. The increasing R&D projects in cancer and other biomedical research, various collaborations with research institutes, and superior healthcare infrastructure in major economies such as China and Japan are the key factors to promote the growth of the market in the region. The increase in demand for highly efficient screening systems and rising drug discovery initiatives among pharmaceuticals and biotechnology companies in the region is anticipated to further promote the growth of the nucleic acid labeling market in the region.



Market Players Outlook



The major companies operating in the nucleic acid labeling market includeF. Hoffman La Roche AG, New England Biolabs, Inc., GE Healthcare, Merck KgaA, Thermo Fisher Scientific Corp., PerkinElmer, Inc., and Promega Corp. among others. The market players operating in the market are actively adopting different growth strategies such as mergers and acquisitions, partnership, collaboration, investment in R&D and new product launches to stay competitive in the marketplace. For instance, in June 2018, New England Biolabs launched NEBNext single-cell input RNA library prep kit for the detection of the increased transcript with ultra-low input amounts.